跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NINTEDANIB TEVA 150 MG CAPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NINTEDANIB TEVA 150 MG CAPSULAS BLANDAS EFG
Approved
STANDARD
NINTEDANIB TEVA 150 MG CAPSULAS BLANDAS EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 8, 2024
Approval ID
ed3c769b3a22ca04
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
ed3c769b3a22ca04
Drug Cima Aemps Name
NINTEDANIB TEVA 150 MG CAPSULAS BLANDAS EFG
Register Number
89431
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2024-03-08
Dosage Form
CÁPSULA BLANDA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Teva Pharma S.L.U.
Active Ingredients
NINTEDANIB ESILATO
180,6 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 8, 2024
Approval ID
ed3c769b3a22ca04
Type
Standard
Back to CIMA-AEMPS Approvals
